| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aldehyde oxidase and its role as a drug metabolizing enzyme
|
Dalvie, Deepak
|
|
2019
|
201 |
C |
p. 137-180
|
article
|
| 2 |
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics
|
Cox, Emily J.
|
|
2019
|
201 |
C |
p. 25-38
|
article
|
| 3 |
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
|
Wang, Yi
|
|
2019
|
201 |
C |
p. 77-93
|
article
|
| 4 |
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
|
Suurs, Frans V.
|
|
2019
|
201 |
C |
p. 103-119
|
article
|
| 5 |
A review on the pathophysiology of asthma remission
|
Carpaij, Orestes A.
|
|
2019
|
201 |
C |
p. 8-24
|
article
|
| 6 |
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
|
Stone, Meredith L.
|
|
2019
|
201 |
C |
p. 202-213
|
article
|
| 7 |
Differential impacts of brain stem oxidative stress and nitrosative stress on sympathetic vasomotor tone
|
Chan, Julie Y.H.
|
|
2019
|
201 |
C |
p. 120-136
|
article
|
| 8 |
DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?
|
Anderluh, Marko
|
|
2019
|
201 |
C |
p. 1-7
|
article
|
| 9 |
Editorial Board
|
|
|
2019
|
201 |
C |
p. ii
|
article
|
| 10 |
Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications
|
Solouki, Sabrina
|
|
2019
|
201 |
C |
p. 39-50
|
article
|
| 11 |
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
|
Clark, Andrew R.
|
|
2019
|
201 |
C |
p. 181-201
|
article
|
| 12 |
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
|
Murai, Junko
|
|
2019
|
201 |
C |
p. 94-102
|
article
|
| 13 |
Targeting opioid dysregulation in depression for the development of novel therapeutics
|
Browne, Caroline A.
|
|
2019
|
201 |
C |
p. 51-76
|
article
|
Journal description